Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
NYU Grossman School of MedicineResidency, Pathology-Anatomic and Clinical, 1994 - 1999
Shanghai Medical UniversityClass of 1983
Certifications & Licensure
TX State Medical License 2000 - 2026- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.Jeffrey A How, Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N Westin
Med. 2025-01-10 - The association of the chemotherapy response score and homologous recombination deficiency in patients undergoing interval tumor reductive surgery following neoadjuvan...Roni Nitecki Wilke, Jinsong Liu, Shannon Neville Westin, Bryan M Fellman, Travis T Sims
International Journal of Gynecological Cancer. 2025-01-06 - Statins inhibit onco-dimerization of the 4Ig isoform of B7-H3.Margie N Sutton, Sarah E Glazer, Ajlan Al Zaki, Arianna Napoli, Ping Yang
Biorxiv. 2024-12-20
Journal Articles
- FABP4 as a Key Determinant of Metastatic Potential of Ovarian CancerJinsong Liu, Anil K Sood, Nature
Press Mentions
Targeted Biologic Inhibition of Both Tumor Cell-Intrinsic and Intercellular CLPTM1L/CRR9-mediated Chemotherapeutic Drug ResistanceMarch 2nd, 2021
MD Anderson Research Highlights for August 2, 2023August 3rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
